SCHEMBL5111571

SCHEMBL5111571

CN1CCN(c2ccc3c(c2)CN(C)CCC3c2cccc(F)c2F)CC1

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 13/20 0.43
SLC6A4 P31645 13/20 0.43
SLC6A3 Q01959 13/20 0.43
CYP2D6 P10635 1/20 0.41
KCNH2 Q12809 1/20 0.41
ADRA2C P18825 1/20 0.40
HTR3A P46098 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MEN1 O00255 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1246023 0.92 SLC6A4 (0.47) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL1247756 0.84 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL1248572 0.82 SLC6A4 (0.42) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL1248286 0.81 SLC6A2 (0.55) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL1247081 0.81 SLC6A2 (0.53) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL1246576 0.80 SLC6A4 (0.51) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL1247033 0.75 SLC6A4 (0.41) SLC6A2SLC6A4SLC6A3
SCHEMBL1249027 0.75 SLC6A2 (0.54) SLC6A2SLC6A4SLC6A3
SCHEMBL1249020 0.75 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL1248418 0.74 SLC6A2 (0.56) SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904069-A2 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN AMR Technology, Inc. (US) 2008-04-02 EP disclosed
WO-2007011820-A2 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN AMR TECHNOLOGY, INC. (US) 2007-01-25 WO disclosed